Hina Waheed Chaudhry
Corporate Officer/Principal bij Icahn School of Medicine at Mount Sinai
Profiel
Hina Waheed Chaudhry was the founder of VentriNova, Inc. which was founded in 2006 where she held the title of Chief Scientific Officer.
Currently, she is the Director of Cardiovascular Regenerative Medicine at Icahn School of Medicine at Mount Sinai.
Dr. Chaudhry has an undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Actieve functies van Hina Waheed Chaudhry
| Bedrijven | Functie | Begin |
|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Eerdere bekende functies van Hina Waheed Chaudhry
| Bedrijven | Functie | Einde |
|---|---|---|
VentriNova, Inc.
 VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Oprichter | - |
Opleiding van Hina Waheed Chaudhry
| Harvard Medical School | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
VentriNova, Inc.
VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Health Technology |
